文献速递贫血与红细胞疾病

一种新型功能获得性PIP4K2A突变升高β-珠蛋白表达并加重α-地中海贫血严重程度

A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia.
PubMed 文献 · Br J Haematol · 2023-07-09

研究在一名表现为中度贫血且Hb H水平较高的女性血红蛋白H病(Hb H病)患者中发现PIP4K2A基因新突变(c.948C>A,p.S316R)。家系血液学分析显示携带该突变者β-珠蛋白表达上调,β/α-珠蛋白比例更失衡,外周红细胞Hb H包涵体增多。功能实验表明突变蛋白稳定性增强、激酶活性升高、对下游蛋白调控更强,提示为功能获得性突变;在HUDEP-2细胞中引入S316R可升高β-珠蛋白表达,进一步抑制红系分化和终末脱核。

要点

  • 在Hb H病患者中鉴定出PIP4K2A新突变c.948C>A(p.S316R)。
  • 携带该突变者β-珠蛋白表达上调,β/α-珠蛋白比例更失衡,Hb H包涵体增多。
  • 突变蛋白稳定性增强、激酶活性升高,提示功能获得性突变;HUDEP-2细胞中S316R升高β-珠蛋白并抑制红系分化与终末脱核。

核心结论

  • S316R突变是与β-珠蛋白表达相关的新遗传因素,PIP4K2A基因是影响α-地中海贫血表型的新潜在修饰基因。

研究设计与样本

  • 病例报告结合家系血液学分析与功能实验,对象为一名表现为中度贫血且Hb H水平较高的女性Hb H病患者及其家庭成员,并在HUDEP-2细胞中引入S316R突变。

主要发现

  • 先证者为女性Hb H病患者,表现为中度贫血和相对较高的Hb H水平,携带PIP4K2A新突变c.948C>A(p.S316R)。
  • 家系血液学分析显示携带该突变的个体β-珠蛋白表达上调,β/α-珠蛋白比例更失衡,外周红细胞Hb H包涵体增多。
  • 功能实验显示突变PIP4K2A蛋白稳定性增强、激酶活性升高、对下游蛋白调控作用更强,提示为功能获得性突变。
  • 在HUDEP-2细胞中引入S316R突变可升高β-珠蛋白表达,进一步抑制红系分化和终末脱核。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Haemoglobin H (Hb H) disease (intermediate status of α-thalassemia) shows marked phenotypic variability from asymptomatic to severe anaemia. Apart from the combined β-thalassemia allele ameliorating clinical severity, reports of genetic modifier genes affecting the phenotype of Hb H disease are scarce which bring inconvenience to precise diagnosis and genetic counselling of the patients. Here, we present a novel mutation (c.948C>A, p.S316R) in the PIP4K2A gene in a female Hb H disease patient who displayed moderate anaemia and a relatively high Hb H level. Haematological analysis in her family members revealed that individuals carrying this mutation have upregulated β-globin expression, leading to a more imbalanced β/α-globin ratio and more Hb H inclusion bodies in peripheral red blood cells. According to functional experiments, the mutant PIP4K2A protein exhibits enhanced protein stability, increased kinase activity and a stronger regulatory effect on downstream proteins, suggesting a gain-of-function mutation. Moreover, introduction of the S316R mutation into HUDEP-2 cells increased expression of β-globin, further inhibiting erythroid differentiation and terminal enucleation. Thus, the S316R mutation is a novel genetic factor associated with β-globin expression, and the PIP4K2A gene is a new potential modifier gene affecting the α-thalassemia phenotype.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Xie H, Liang G, et al. A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia. Br J Haematol. 2023. PMID: 37423903. doi:10.1111/bjh.18967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。